MHC Class I-Restricted TCR-Transgenic CD4+ T Cells Against STEAP1 Mediate Local Tumor Control of Ewing Sarcoma In Vivo

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Post‐relapse survival in patients with Ewing sarcomacohort · 2015 · 64 citations
2. 2Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcomaOriginal Research · 2019 · 147 citations
3. 3CD4+ T Cell and NK Cell Interplay Key to Regression of MHC Class Ilow Tumors upon TLR7/8 Agonist TherapyOriginal Research · 2017 · 44 citations
4. 4Beyond Tumor Suppression: Senescence in Cancer Stemness and Tumor DormancyReview · 2020 · 97 citations
5. 5Human MHC Class I-restricted high avidity CD4⁺T cells generated by co-transfer of TCR and CD8 mediate efficient tumor rejection in vivoOriginal Research · 2012 · 52 citations